Filter Results:
(111)
Show Results For
- All HBS Web
(111)
- News (32)
- Research (65)
- Events (1)
- Multimedia (1)
- Faculty Publications (42)
Show Results For
- All HBS Web
(111)
- News (32)
- Research (65)
- Events (1)
- Multimedia (1)
- Faculty Publications (42)
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
Business School, while Devin is professor emeritus from Swarthmore College. Sarah Jane Gilbert: Can you explain what accidental innovation is? What led to your interest in researching this concept? Robert Austin: Historical accounts of many important View Details
Keywords: by Sarah Jane Gilbert
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- Web
Industry Information - Alumni
biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provide local expertise along with a global perspective. BioSpace Leading online... View Details
- 01 Dec 2013
- News
To Market, to Market
which depends on the merging of breakthrough scientific ideas and great business leadership," said Dean Nitin Nohria. By focusing on technologies that have great potential to impact human lives and by enabling business leaders to take these View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
biotech companies—as a function of cost, time, and failure modes—tend to risk pivot on one program, one clinical trial, one outcome,” he observes. “Our company is the leader in mining muscle biology for drug View Details
Keywords: Deborah Blagg
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat cancer and neurodegenerative disorders, and AI-driven medical... View Details
- 15 Dec 2024
- News
After Ozempic
affiliate in Plainsboro, New Jersey. That all changed when its breakthrough drug for type 2 diabetes, Ozempic, hit the market in 2018. By some biochemical mystery, it also turned out to be a powerful tool for weight loss—which led to the... View Details
- 20 Aug 2014
- News
With No Time to Lose
an effective biomarker—a kind of test that could measure the progression of ALS over a short period of time—did not yet exist. Without it, drug trials relied on longer, more costly observations of disease progression. Next, collaboration... View Details
Keywords: Margie Kelley
- 17 Feb 2016
- Blog Post
Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference
markets, to changing the drug discovery process to be more patient-centric. A highlight of the panel sessions was when Adam Koppel, EVP of Strategy and Corporate Development at Biogen and Health Care... View Details
Keywords: Health Care
- 01 Jun 2018
- News
Floor It
so that we can help get clinical trials done and move the pace of discovery even quicker.” How do they expect to get there? Here, a look at the accelerator’s model, which comprises four work streams, each inspecting a different part of... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
drug business. They relied, however, on licensing rather than building their own in-house capabilities for drug discovery and commercialization. In the low-tech OTC... View Details
- 01 Sep 2008
- News
Mara Aspinall
higher efficacy rate — 80 percent or more. Is 80 percent efficacy unusual for drugs currently on the market? Across all patients and diseases, drug efficacy averages 50 percent, so half the time they bring... View Details
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
Keywords: Janelle Nanos
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
Millennium. "With the whole genome known, the process of drug discovery in the future will involve comprehensively identifying all molecular interactions for a drug." Genetic information should be... View Details
- 01 Jun 2000
- News
The Business of Biotech
which a drug is interacting, we can predict the basis for toxicity as well as efficacy," says Alan Crane of Millennium. "With the whole genome known, the process of drug View Details
Keywords: Julia Hanna
- 14 Apr 2014
- News
The Puzzle of Life
capitalize companies that may not make sense for venture funds but do make sense for smart angels who have more patience than most VCs." Among those companies: Rani Therapeutics, an early-stage venture focused on making injectable biological View Details
- 01 Dec 2013
- News
Your Own Medicine
is progressing daily. You can't settle for the typical schedule of drug discovery and development. So forget the drug companies. We'll form our own. “Well, you can't just tell... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new... View Details